Preoperative administration of Omega-3 fatty acids on postoperative pain and acute-phase reactants in patients undergoing Roux-en-Y gastric bypass : A randomized clinical trial

Copyright © 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved..

BACKGROUND: The term "Immunonutrition" (IMN) describes the enteral administration of certain substrates with a theoretical immunomodulating function. From all the elements conforming these IMN formulas, Omega-3 fatty acids (O3FA) are hypothesized to be the most important component for immunomodulation, with increased anti-inflammatory and antioxidant effect.

PATIENTS AND METHODS: A prospective randomized clinical trial of all the patients undergoing laparoscopic Roux-en-Y gastric bypass was performed. Patients were randomly assigned into 2 groups: those patients receiving a preoperative balanced energy high-protein formula (Control Group) and those ones who received the same preoperative nutritional formula enriched with O3FA (Experimental Group). In both groups, there was a restriction to 900 Kcal/day. Nutritional intervention started 10 days before surgery and was maintained up to 8 h before the surgical act. Preoperative weight loss, postoperative pain, complications and acute phase reactants were investigated.

RESULTS: 40 patients were included in the study, 20 in each group. Preoperative excess weight loss (EWL) with the prescribed treatment was 10.6 ± 7.7% in Control Group and 14.1 ± 5.8% in the Experimental Group (p = 0.024). Mean postoperative pain was 25 ± 9.2 mm in Control group and 10,9 ± 4,4 mm in Experimental Group (p = 0.015). CRP determined 24 h after surgery was significantly lower in the Experimental Group than in the Control Group. There were not significant differences in complications, mortality or readmission rates between groups.

CONCLUSIONS: The use of a nutritional supplement enriched with O3FA is associated with a greater preoperative weight loss, reduced postoperative pain and decreased postoperative levels of C reactive protein.

Errataetall:

CommentIn: Clin Nutr. 2020 Apr;39(4):1301. - PMID 32139109

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:38

Enthalten in:

Clinical nutrition (Edinburgh, Scotland) - 38(2019), 4 vom: 15. Aug., Seite 1588-1593

Sprache:

Englisch

Beteiligte Personen:

Ruiz-Tovar, Jaime [VerfasserIn]
Blanca, Maria [VerfasserIn]
Garcia, Alejandro [VerfasserIn]
Gonzalez, Juan [VerfasserIn]
Gutierrez, Sonsoles [VerfasserIn]
Paniagua, Amalia [VerfasserIn]
Prieto, Maria Jose [VerfasserIn]
Ramallo, Luisa [VerfasserIn]
Llanos, Lucia [VerfasserIn]
Duran, Manuel [VerfasserIn]

Links:

Volltext

Themen:

9007-41-4
C reactive protein
C-Reactive Protein
Fatty Acids, Omega-3
Immunonutrition
Journal Article
Omega-3 fatty acids
Postoperative pain
Preoperative excess weight loss
Randomized Controlled Trial
Sleeve gastrectomy

Anmerkungen:

Date Completed 22.06.2020

Date Revised 12.02.2021

published: Print-Electronic

ClinicalTrials.gov: NCT03010280

CommentIn: Clin Nutr. 2020 Apr;39(4):1301. - PMID 32139109

Citation Status MEDLINE

doi:

10.1016/j.clnu.2018.07.026

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM287364178